{"id":78296,"date":"2024-03-22T16:20:00","date_gmt":"2024-03-22T16:20:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/"},"modified":"2024-06-26T11:12:13","modified_gmt":"2024-06-26T11:12:13","slug":"infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/","title":{"rendered":"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#8217;assist\u00e8ncia i participaci\u00f3"},"content":{"rendered":"<p>\tEl president del f\u00f2rum i del COFM, Manuel Mart\u00ednez del Peral, va celebrar a la clausura l&#8217;edici\u00f3 \u201cde major participaci\u00f3 de la hist\u00f2ria\u201d: \u201cLa societat necessita dels farmac\u00e8utics com a part de la soluci\u00f3 als desafiaments sanitaris i socials que afrontem\u201d<br \/>\n\tJos\u00e9 Manuel Becerra, director del congr\u00e9s Infarma Madrid 2024, va subratllar el comprom\u00eds d&#8217;aquesta edici\u00f3 amb la innovaci\u00f3, la participaci\u00f3 i l&#8217;aportaci\u00f3 d&#8217;idees, experi\u00e8ncies i solucions perqu\u00e8 la professi\u00f3 farmac\u00e8utica aporti m\u00e9s valor a les persones<br \/>\n\tJordi Casas, president del Col\u00b7legi de Farmac\u00e8utics de Barcelona, va recollir el testimoni per acollir la pr\u00f2xima edici\u00f3 d\u2019Infarma a Barcelona del 25 al 27 de mar\u00e7 de 2025<br \/>\n\tAgust\u00edn Torres, president de CloserStill, va qualificar de \u201cimpressionant\u201d el creixement de Infarma, que va superar \u201ctotes les expectatives\u201d<\/p>\n<p><em>Madrid, 22 de mar\u00e7 de 2024. &#8211; <\/em>\u201c<strong>Infarma Madrid 2024 ha superat amb escreix les previsions m\u00e9s optimistes que tots ten\u00edem. Estem, sense lloc a dubte, davant el Infarma m\u00e9s multitudinari, de m\u00e9s assist\u00e8ncia i de major participaci\u00f3 de la hist\u00f2ria<\/strong>\u201d. Aix\u00ed va definir Manuel Mart\u00ednez del Peral, president d\u2019<strong>Infarma Madrid 2024<\/strong> i del Col\u00b7legi Oficial de Farmac\u00e8utics de Madrid (COFM), la qual cosa ha estat aquesta edici\u00f3 del Congr\u00e9s Europeu de Farm\u00e0cia i Sal\u00f3 de Medicaments i Parafarm\u00e0cia, organitzat pels Col\u00b7legis de Farmac\u00e8utics de Madrid i Barcelona (COFB) i CloserStill en el recinte d\u2019IFEMA, del 19 al 21 de mar\u00e7.<\/p>\n<p>El president del COFM va subratllar a la clausura el car\u00e0cter col\u00b7laboratiu i d&#8217;avantguarda que t\u00e9 aquest f\u00f2rum, constru\u00eft sobre l&#8217;eix Madrid-Barcelona amb el m\u00fascul d&#8217;una empresa com CloserStill. \u201cLa farm\u00e0cia espanyola necessita un Infarma que cada any posi sobre la taula les respostes que els farmac\u00e8utics podem donar als grans desafiaments socials i sanitaris de l&#8217;actualitat, perqu\u00e8 <strong>la societat necessita dels farmac\u00e8utics com a part de la soluci\u00f3 a aquests desafiaments<\/strong>\u201d, va afirmar.<\/p>\n<p>En aquest sentit, <strong>va destacar el valor d\u2019Infarma com a espai de trobada per estr\u00e8nyer la col\u00b7laboraci\u00f3 entre els farmac\u00e8utics, la ind\u00fastria, la distribuci\u00f3 i les companyies de serveis <\/strong>amb l&#8217;objectiu com\u00fa de refor\u00e7ar la cura de la salut i la qualitat de vida de les persones.<\/p>\n<p><strong>Mart\u00ednez del Peral va lliurar durant la clausura el testimoni a Jordi Casas<\/strong>, president del COFB i vicepresident del congr\u00e9s, <strong>per a l&#8217;organitzaci\u00f3 d\u2019Infarma Barcelona 2025<\/strong>, que se celebrar\u00e0 del <strong>25 al 27 de mar\u00e7 del pr\u00f2xim any.<\/strong><\/p>\n<p><strong><\/strong><\/p>\n<p>Casas va destacar que aquesta edici\u00f3 \u201cha estat un \u00e8xit absolut\u201d i que<strong> ha perm\u00e8s que Infarma \u201ccontinu\u00ef sent el punt de refer\u00e8ncia global del sector<\/strong>\u201d. Al costat d&#8217;aix\u00f2, va confirmar el comprom\u00eds de comen\u00e7ar a treballar \u201cdes d&#8217;avui\u201d per a donar forma a Infarma 2025 a Barcelona i aconseguir que aquesta trobada continu\u00ef creixent i millorant.<\/p>\n<p><strong>Agust\u00edn Torres<\/strong>, president de CloserStill, va reiterar el \u201cgran \u00e8xit\u201d aconseguit en aquesta edici\u00f3: <strong>\u201cHa estat un honor ser testimoni de l&#8217;impressionant creixement i dels assoliments aconseguits durant aquests dies<\/strong>. Infarma 2024 ha superat totes les nostres expectatives amb una assist\u00e8ncia que ha superat amb escreix els objectius que ens hav\u00edem marcat\u201d.<\/p>\n<p>Les xifres aconseguides al tancament de l&#8217;esdeveniment evidencien b\u00e9 aquest \u00e8xit, ja que s&#8217;ha comptat amb una <strong>superf\u00edcie de 32.000 metres quadrats<\/strong> i amb una assist\u00e8ncia de m\u00e9s de<strong> 25.400 visitants \u00fanics\/dia (un 24% m\u00e9s que a Infarma Madrid 2022)<\/strong>, <strong>300 expositors<\/strong>, una mica m\u00e9s de <strong>4.000 congressistes<\/strong> i m\u00e9s de <strong>1.000 marques representades.<\/strong><\/p>\n<p><strong>Jos\u00e9 Manuel Becerra<\/strong>, director del congr\u00e9s de Infarma Madrid 2024 i vocal de Titulars d&#8217;Oficina de Farm\u00e0cia del COFM, va exposar les <a href=\"https:\/\/www.cofm.es\/recursos\/doc\/portal\/2015\/10\/26\/conclusiones-infarma-madrid-2024.docx\" target=\"_blank\" rel=\"noopener\">conclusions <\/a>aconseguides en aquests tres dies de trobada i va destacar el comprom\u00eds de complir amb un <strong>lema tan \u201cambici\u00f3s\u201d <\/strong>com el triat per a enguany, <strong>\u201cPosa la teva farm\u00e0cia a l&#8217;avantguarda\u201d<\/strong>, ja que buscava reflectir l&#8217;aposta d&#8217;aquesta edici\u00f3 amb la innovaci\u00f3, la participaci\u00f3 activa i l&#8217;aportaci\u00f3 d&#8217;idees, experi\u00e8ncies i solucions perqu\u00e8 la farm\u00e0cia i la professi\u00f3 farmac\u00e8utica estiguin millor preparades davant els grans reptes del present i del futur, tant des del punt de vista assistencial com cient\u00edfic i empresarial. \u201cCrec, honestament, que hem superat els objectius proposats\u201d, va ressaltar.<\/p>\n<p><strong>Alt nivell de les comunicacions cient\u00edfiques<\/strong><\/p>\n<p>Tamb\u00e9 durant l&#8217;acte de clausura es van<strong> lliurar els premis a les millors comunicacions cient\u00edfiques presentades al congr\u00e9s.<\/strong> La relaci\u00f3 de guardons la va donar <strong>Rafael Are\u00f1as<\/strong>, coordinador cient\u00edfic d&#8217;aquesta edici\u00f3 i vicepresident 3r del COFM, qui va destacar el \u201c<strong>nivell alt\u00edssim<\/strong>\u201d <strong>de tots els treballs (166 p\u00f2sters admesos d&#8217;un total de 201 presentats)<\/strong>.<\/p>\n\n<p>Finalment, d&#8217;una relaci\u00f3 final de<strong> 15 comunicacions, les tres guardonades van ser:<\/strong><\/p>\n<p>\t<strong>Primer premi:<\/strong>\u00a0&#8220;<strong><a href=\"https:\/\/www.cofm.es\/recursos\/img\/portal\/2015\/04\/24\/estudio-de-estabilidad-de-emulsiones-ow.jpg?utm_campaign=np-infarma-madrid-2024-supera-las-previsiones-mas-optimistas-de-asistencia-y-participacion&amp;utm_medium=email&amp;utm_source=acumbamail\" target=\"_blank\" rel=\"noopener\">Estudio de estabilidad de emulsiones o\/w de \u00e1cido retinoico 0,01%, hidroquinona 5%, hidrocortisona 1% y \u00e1cido tranex\u00e1mico 3% elaboradas en laboratorios formulistas<\/a><\/strong>&#8220;, de Uriel Gallego, M., Melendo Vidal, AP., Ben\u00edtez Ben\u00edtez, MP., Abarca Lachen, E., Pezo Pinya, D., G\u00f3mez Rinc\u00f3n, C. PACMI (Programa de Aseguramiento de la Calidad del medicamento Individualizado). Universidad San Jorge.<br \/>\n\t<strong>Segon premi: <\/strong>\u201c<a href=\"https:\/\/www.cofm.es\/recursos\/img\/portal\/2015\/04\/24\/el-papel-del-radiofarmaceutico-en-los-ensayos-clinicos.jpg?utm_campaign=np-infarma-madrid-2024-supera-las-previsiones-mas-optimistas-de-asistencia-y-participacion&amp;utm_medium=email&amp;utm_source=acumbamail\" target=\"_blank\" rel=\"noopener\">El Papel del Radiofarmac\u00e9utico en los Ensayos Cl\u00ednicos<\/a>\u201d, de Pareja del Riu, F., Fern\u00e1ndez Gonz\u00e1lez, A., Quincoces Fern\u00e1ndez, G., Ramos Membrive, R., Pe\u00f1uelas S\u00e1nchez, I. Cl\u00ednica de la Universitat de Navarra.<br \/>\n\t<strong>Tercer Premi:<\/strong> \u201c<a href=\"http:\/\/comunicacion.cofm.es\/url\/ver\/582525705\/2598248\/a6a31de9b32ee59360291220b410a8c7\" target=\"_blank\" rel=\"noopener\">JunTOS. Cuidado farmac\u00e9utico al paciente trasplantado<\/a>\u201d, de Mart\u00ednez Garc\u00eda, R., Herranz Alonso, A., Garrido Olmedo, JE., Blanes Jim\u00e9nez, A., Fern\u00e1ndez Moriano, C., Mart\u00edn Guti\u00e9rrez, L (Grup de Treball Junts \u2013 Consejo General de Colegios Oficiales de Farmac\u00e9uticos).<\/p>\n<p><strong>Recaptaci\u00f3 ben\u00e8fica de \u2018Infarma Solidari\u2019<\/strong><\/p>\n<p>L&#8217;edici\u00f3 d\u2019Infarma Madrid 2024 tamb\u00e9 va tenir la seva part de <strong>comprom\u00eds social <\/strong>a trav\u00e9s <strong>d\u2019Infarma Solidari<\/strong>, que va celebrar un <strong>concert ben\u00e8fic <\/strong>mitjan\u00e7ant el qual es van <strong>recaptar 25.540 euros<\/strong>, destinats a donar suport a un projecte liderat per la <strong>Fundaci\u00f3n El Alto <\/strong>de capacitaci\u00f3 t\u00e8cnica d&#8217;alumnes de Farm\u00e0cia a la Universidad de Makerere i la millora dels serveis de Farm\u00e0cia a l&#8217;Hospital de Saint Joseph, de Kitgum, a Uganda.<\/p>","protected":false},"excerpt":{"rendered":"<p>El president del f\u00f2rum i del COFM, Manuel Mart\u00ednez del Peral, va celebrar a la clausura l&#8217;edici\u00f3 \u201cde major participaci\u00f3 de la hist\u00f2ria\u201d: \u201cLa societat necessita dels farmac\u00e8utics com a part de la soluci\u00f3 als desafiaments sanitaris i socials que afrontem\u201d Jos\u00e9 Manuel Becerra, director del congr\u00e9s Infarma Madrid 2024, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":77842,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060],"tags":[],"class_list":["post-78296","post","type-post","status-publish","format-aside","has-post-thumbnail","hentry","category-notes-premsa","post_format-post-format-aside"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#039;assist\u00e8ncia i participaci\u00f3 - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#039;assist\u00e8ncia i participaci\u00f3 - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El president del f\u00f2rum i del COFM, Manuel Mart\u00ednez del Peral, va celebrar a la clausura l&#8217;edici\u00f3 \u201cde major participaci\u00f3 de la hist\u00f2ria\u201d: \u201cLa societat necessita dels farmac\u00e8utics com a part de la soluci\u00f3 als desafiaments sanitaris i socials que afrontem\u201d Jos\u00e9 Manuel Becerra, director del congr\u00e9s Infarma Madrid 2024, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-22T16:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-26T11:12:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#8217;assist\u00e8ncia i participaci\u00f3\",\"datePublished\":\"2024-03-22T16:20:00+00:00\",\"dateModified\":\"2024-06-26T11:12:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\"},\"wordCount\":1056,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg\",\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\",\"name\":\"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d'assist\u00e8ncia i participaci\u00f3 - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg\",\"datePublished\":\"2024-03-22T16:20:00+00:00\",\"dateModified\":\"2024-06-26T11:12:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg\",\"width\":2560,\"height\":1673},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#8217;assist\u00e8ncia i participaci\u00f3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d'assist\u00e8ncia i participaci\u00f3 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/","og_locale":"ca_ES","og_type":"article","og_title":"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d'assist\u00e8ncia i participaci\u00f3 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El president del f\u00f2rum i del COFM, Manuel Mart\u00ednez del Peral, va celebrar a la clausura l&#8217;edici\u00f3 \u201cde major participaci\u00f3 de la hist\u00f2ria\u201d: \u201cLa societat necessita dels farmac\u00e8utics com a part de la soluci\u00f3 als desafiaments sanitaris i socials que afrontem\u201d Jos\u00e9 Manuel Becerra, director del congr\u00e9s Infarma Madrid 2024, [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2024-03-22T16:20:00+00:00","article_modified_time":"2024-06-26T11:12:13+00:00","og_image":[{"width":2560,"height":1673,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#8217;assist\u00e8ncia i participaci\u00f3","datePublished":"2024-03-22T16:20:00+00:00","dateModified":"2024-06-26T11:12:13+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/"},"wordCount":1056,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg","articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/","url":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/","name":"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d'assist\u00e8ncia i participaci\u00f3 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg","datePublished":"2024-03-22T16:20:00+00:00","dateModified":"2024-06-26T11:12:13+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg","width":2560,"height":1673},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2024\/03\/22\/infarma-madrid-2024-supera-les-previsions-mes-optimistes-dassistencia-i-participacio-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"\u2018Infarma Madrid 2024\u2019 supera les previsions m\u00e9s optimistes d&#8217;assist\u00e8ncia i participaci\u00f3"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-scaled.jpeg",2560,1673,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-150x150.jpeg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-300x196.jpeg",300,196,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-768x502.jpeg",768,502,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-1024x669.jpeg",1024,669,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-1536x1004.jpeg",1536,1004,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-2048x1338.jpeg",2048,1338,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/03\/b2866192-4afe-4d78-ae16-6df4c433f1c9-SzuwjX-18x12.jpeg",18,12,true]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El president del f\u00f2rum i del COFM, Manuel Mart\u00ednez del Peral, va celebrar a la clausura l&#8217;edici\u00f3 \u201cde major participaci\u00f3 de la hist\u00f2ria\u201d: \u201cLa societat necessita dels farmac\u00e8utics com a part de la soluci\u00f3 als desafiaments sanitaris i socials que afrontem\u201d Jos\u00e9 Manuel Becerra, director del congr\u00e9s Infarma Madrid 2024, [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/78296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=78296"}],"version-history":[{"count":1,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/78296\/revisions"}],"predecessor-version":[{"id":78324,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/78296\/revisions\/78324"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/77842"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=78296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=78296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=78296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}